Arnold W. Klein, M.D. y su lucha contra el SIDA
Arnold W. Klein, M.D.
Joined the board of an amfAR predecessor, the National AIDS Research Foundation (NARF)**, in August 1985. Became a founding director of amfAR in September 1985, following unification of the Los Angeles-based NARF and the New York-based AIDS Medical Association. Serves on board development committee. Expertise in dermatology and cosmetic surgery; among the first in Los Angeles to diagnose Kaposi’s sarcoma in young patients. Was early fund-raiser for amfAR and AIDS research, initiating contact with Getty family and later appealing to Jennifer Jones Simon Foundation. Mrs. Simon’s substantial 1998 donation to amfAR honored Dr. Klein. Currently is founding chair of the honorary committee of The Elizabeth Taylor Endowment for the UCLA Center for Clinical AIDS Research and Education.
A prolific writer, textbook author, editor, reviewer, and consultant, Dr. Klein has maintained a private dermatology practice in Beverly Hills for more than 30 years. He is also a professor of dermatology and medicine at the David Geffen School of Medicine of the University of California, Los Angeles (UCLA). Recently, he was honored by the establishment of a named chair in dermatology at UCLA and is himself the founder of UCLA’s Rose Tarlow/Arnold W. Klein Fund for Breast Cancer Treatment. He is an attending physician at the Cedars-Sinai Medical Center and, in addition to the amfAR board, sits on the board of the Hereditary Disease Foundation.
Physician in private practice. He lives in Los Angeles, CA.
- **In 1985, Miss Taylor joined with Dr. Mathilde Krim and a small group of physicians and scientists to form the American Foundation for AIDS Research (amfAR). As amfAR’s Founding National Chairman, she used her celebrity to take the issue of HIV/AIDS to the mainstream media.
Founded in 1985, amfAR is dedicated to ending the global AIDS epidemic through innovative research. With the freedom and flexibility to respond quickly to emerging areas of scientific promise, amfAR plays a catalytic role in accelerating the pace of HIV/AIDS research and achieving real breakthroughs. amfAR-funded research has increased our understanding of HIV and has helped lay the groundwork for major advances in the study and treatment of HIV/AIDS. Since 1985, amfAR has invested nearly $325 million in its mission and has awarded grants to more than 2,000 research teams worldwide.